Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.11 USD | +3.77% | +7.99% | +4.83% |
04/06 | Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating | MT |
28/05 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.83% | 342.22Cr | |
+43.48% | 75TCr | |
+34.11% | 61TCr | |
-6.27% | 36TCr | |
+18.84% | 33TCr | |
+6.55% | 29TCr | |
+18.08% | 25TCr | |
-3.44% | 21TCr | |
+11.35% | 21TCr | |
+2.29% | 17TCr |
- Stock Market
- Equities
- CORT Stock
- News Corcept Therapeutics Incorporated
- Truist Securities Downgrades Corcept Therapeutics to Hold From Buy; Price Target is $30